Your browser doesn't support javascript.
loading
Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
Hamy, Anne-Sophie; Derosa, Lisa; Valdelièvre, Constance; Yonekura, Satoru; Opolon, Paule; Priour, Maël; Guerin, Julien; Pierga, Jean-Yves; Asselain, Bernard; De Croze, Diane; Pinheiro, Alice; Lae, Marick; Talagrand, Laure-Sophie; Laas, Enora; Darrigues, Lauren; Grandal, Beatriz; Marangoni, Elisabetta; Montaudon, Elodie; Kroemer, Guido; Zitvogel, Laurence; Reyal, Fabien.
Afiliação
  • Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.
  • Derosa L; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Valdelièvre C; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
  • Yonekura S; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
  • Opolon P; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Priour M; Department of Surgery, Institut Curie, Paris, France.
  • Guerin J; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
  • Pierga JY; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
  • Asselain B; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • De Croze D; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
  • Pinheiro A; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
  • Lae M; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Talagrand LS; Informatics Department, Institut Curie, Paris, France.
  • Laas E; Informatics Department, Institut Curie, Paris, France.
  • Darrigues L; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Grandal B; Biostatistics Department, Institut Curie, Paris, France.
  • Marangoni E; Tumor Biology, Institut Curie, Paris, France.
  • Montaudon E; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.
  • Kroemer G; Tumor Biology, Institut Curie, Paris, France.
  • Zitvogel L; Department of Surgery, Institut Curie, Paris, France.
  • Reyal F; Department of Surgery, Institut Curie, Paris, France.
Oncoimmunology ; 9(1): 1677427, 2020.
Article em En | MEDLINE | ID: mdl-32002287
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França